Suraiya Dubash

507 total citations
24 papers, 285 citations indexed

About

Suraiya Dubash is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Suraiya Dubash has authored 24 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Suraiya Dubash's work include Medical Imaging Techniques and Applications (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Suraiya Dubash is often cited by papers focused on Medical Imaging Techniques and Applications (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Suraiya Dubash collaborates with scholars based in United Kingdom, Italy and United States. Suraiya Dubash's co-authors include Tara Barwick, Sameer Khan, Henry Tam, Eric O. Aboagye, Mubarik Arshad, Rohini Sharma, Kasia Kozlowski, Marianna Inglese, Louis Allott and Francesco Mauri and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases and Molecules.

In The Last Decade

Suraiya Dubash

21 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suraiya Dubash United Kingdom 9 161 104 78 46 44 24 285
Sami Suilamo Finland 13 239 1.5× 124 1.2× 88 1.1× 50 1.1× 65 1.5× 22 390
Reyhaneh Manafi‐Farid Iran 12 208 1.3× 175 1.7× 118 1.5× 35 0.8× 37 0.8× 25 339
C. Zwarthoed France 5 175 1.1× 114 1.1× 93 1.2× 56 1.2× 41 0.9× 12 329
Mahmoud Moustafa Germany 11 71 0.4× 166 1.6× 88 1.1× 91 2.0× 46 1.0× 22 312
Pengfei Jiang China 9 103 0.6× 110 1.1× 134 1.7× 98 2.1× 41 0.9× 23 333
Henrik H. El Ali Denmark 11 183 1.1× 36 0.3× 72 0.9× 59 1.3× 23 0.5× 24 332
Daniele Scartoni Italy 9 110 0.7× 212 2.0× 76 1.0× 44 1.0× 44 1.0× 45 351
Sofia C. Vaz Portugal 12 245 1.5× 176 1.7× 95 1.2× 29 0.6× 68 1.5× 36 429
Rakhee Vatsa India 11 206 1.3× 64 0.6× 109 1.4× 28 0.6× 17 0.4× 42 331
Evin Gulbahce United States 8 224 1.4× 52 0.5× 65 0.8× 80 1.7× 72 1.6× 15 416

Countries citing papers authored by Suraiya Dubash

Since Specialization
Citations

This map shows the geographic impact of Suraiya Dubash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suraiya Dubash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suraiya Dubash more than expected).

Fields of papers citing papers by Suraiya Dubash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suraiya Dubash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suraiya Dubash. The network helps show where Suraiya Dubash may publish in the future.

Co-authorship network of co-authors of Suraiya Dubash

This figure shows the co-authorship network connecting the top 25 collaborators of Suraiya Dubash. A scholar is included among the top collaborators of Suraiya Dubash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suraiya Dubash. Suraiya Dubash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polychronis, Andreas, Γεώργιος Αντωνίου, Arshi Denton, et al.. (2024). 85 Assessing tolerability and toxicity of adjuvant Osimertinib following tumour resection of early-stage EGFR-mutated non-small cell lung cancer through real-world data. Lung Cancer. 190. 107646–107646.
3.
Afxentiou, Thalia, Andreas Polychronis, Arshi Denton, et al.. (2024). 63 Real-world outcomes of Nivlolumab-Ipilimumab combination therapy in unresectable malignant mesothelioma: Mount Vernon Cancer Centre Experience. Lung Cancer. 190. 107624–107624.
4.
Polychronis, Andreas, et al.. (2024). 93 Evaluating real-world tepotinib-related toxicity data across five UK cancer units- A case-series. Lung Cancer. 190. 107654–107654.
5.
Madani, Hardi, et al.. (2024). The Evolving Role of Artificial Intelligence in Radiotherapy Treatment Planning—A Literature Review. Clinical Oncology. 36(10). 596–605. 6 indexed citations
6.
Islam, Shahriar, Marianna Inglese, Matthew Grech‐Sollars, et al.. (2023). Feasibility of [18F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 50(13). 3982–3995. 8 indexed citations
7.
Challapalli, Amarnath, Tara Barwick, Suraiya Dubash, et al.. (2023). Bench to Bedside Development of [18F]Fluoromethyl-(1,2-2H4)choline ([18F]D4-FCH). Molecules. 28(24). 8018–8018. 1 indexed citations
8.
Li, Yunqing, Marianna Inglese, Suraiya Dubash, et al.. (2021). Consideration of Metabolite Efflux in Radiolabelled Choline Kinetics. Pharmaceutics. 13(8). 1246–1246. 5 indexed citations
10.
Sharma, Rohini, Marianna Inglese, Suraiya Dubash, et al.. (2020). Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using 18F-Fluorothymidine PET. Journal of Nuclear Medicine. 61(12). 1743–1748. 12 indexed citations
11.
Allott, Louis, Suraiya Dubash, & Eric O. Aboagye. (2020). [18F]FET-βAG-TOCA: The Design, Evaluation and Clinical Translation of a Fluorinated Octreotide. Cancers. 12(4). 865–865. 11 indexed citations
12.
Dubash, Suraiya, Nicholas Keat, Kasia Kozlowski, et al.. (2020). Clinical translation of 18F-fluoropivalate – a PET tracer for imaging short-chain fatty acid metabolism: safety, biodistribution, and dosimetry in fed and fasted healthy volunteers. European Journal of Nuclear Medicine and Molecular Imaging. 47(11). 2549–2561. 10 indexed citations
14.
Sharma, Rohini, Marianna Inglese, Suraiya Dubash, et al.. (2019). [18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer. European Journal of Nuclear Medicine and Molecular Imaging. 47(5). 1239–1251. 14 indexed citations
15.
16.
Dubash, Suraiya, Kathrin Heinzmann, Francesco Mauri, et al.. (2018). Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 45(13). 2285–2299. 31 indexed citations
17.
Dubash, Suraiya, Nicholas Keat, Paola Mapelli, et al.. (2016). Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors. Journal of Nuclear Medicine. 57(8). 1207–1213. 33 indexed citations
18.
Dubash, Suraiya, et al.. (2015). The emerging role of positron emission tomography in hepatocellular carcinoma. PubMed. 2(2). 191–200. 7 indexed citations
20.
Hoskin, Peter & Suraiya Dubash. (2012). Bladder conservation for muscle-invasive bladder cancer. Expert Review of Anticancer Therapy. 12(8). 1015–1020. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026